Chronic myeloid leukemia in a man with papillary carcinoma of the thyroid treated with radioactive iodine

被引：8
|
作者：
Pavithran, K [1 ]
Doval, DC [1 ]
机构：
[1] Rajiv Gandhi Canc Inst & Res, New Delhi 110085, India
来源：
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS | 2005年 / 28卷 / 02期
关键词：
papillary thyroid carcinoma; I-131; chronic myeloid leukemia; secondary CML;
D O I：
10.1097/01.coc.0000143845.79889.33
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Leukemia as a second malignancy after treatment of thyroid cancer is rare. Most cases reported in the literature-have occurred after cumulative doses higher than 800 mCi and it is most commonly acute leukemias. We report a case of chronic myeloid leukemia (CML) occurring in a 40-year-old man 14 years after treatment of papillary thyroid carcinoma. Our patient had the longest interval between the diagnosis of CML and administration of I-131.
引用
收藏
页码：216 / 216
页数：1
相关论文
共 50 条
  • [1] Chronic myeloid leukemia in a woman with papillary carcinoma of the thyroid treated with radioactive iodine
    Alfiar, F
    Amato, D
    Lipton, JH
    LEUKEMIA & LYMPHOMA, 1997, 27 (3-4) : 365 - 367
  • [2] Selpercatinib prior to radioactive iodine for pediatric papillary thyroid carcinoma
    Chiu, Harvey K.
    Nowicki, Theodore S.
    Livhits, Masha J.
    Wu, James X.
    Federman, Noah
    JOURNAL OF PEDIATRIC ENDOCRINOLOGY & METABOLISM, 2024, 37 (11) : 1009 - 1014
  • [3] CHRONIC MYELOID-LEUKEMIA FOLLOWING RADIOACTIVE IODINE I-131 THERAPY OF THYROID-CANCER
    HEGDE, UP
    GOPAL, R
    NANJANGUD, G
    ADVANI, SH
    LEUKEMIA & LYMPHOMA, 1991, 5 (2-3) : 215 - 217
  • [4] Efficacy of postoperative radioactive iodine therapy for patients with low and intermediate risk papillary thyroid carcinoma
    Lee, Hyeon A.
    Song, Chang Myeon
    Ji, Yong Bae
    Kim, Ji Young
    Lee, Soo Jin
    Choi, Yun Young
    Tae, Kyung
    ENDOCRINE, 2025, 87 (02) : 685 - 696
  • [5] Predictors of response to Radioactive Iodine Therapy in Intermediate and high risk patients with papillary thyroid carcinoma
    Keshavarzi, Azam
    Alaei-Shahmiri, Fariba
    Fallahi, Babak
    Emami, Zahra
    Malek, Mojtaba
    Khamseh, Mohammad E.
    BMC ENDOCRINE DISORDERS, 2024, 24 (01)
  • [6] Association between excessive chronic iodine exposure and the occurrence of papillary thyroid carcinoma
    Huang, Fengyan
    Cong, Wei
    Xiao, Juan
    Zhou, Yong
    Gong, Maosong
    Sun, Jingfu
    Shan, Liqun
    Xiao, Qiang
    Wang, Lihua
    Liu, Jianing
    Yu, Zhigang
    Jia, Hongying
    ONCOLOGY LETTERS, 2020, 20 (05)
  • [7] Two Cases of Rapidly Growing Papillary Thyroid Carcinoma After Radioactive Iodine Therapy for Graves' Disease
    Tachibana, Seigo
    Yokoi, Tadao
    Sato, Shinya
    Nakatake, Nobuhiro
    Fukata, Shuji
    Tajiri, Junichi
    Yamashita, Hiroyuki
    JOURNAL OF ENDOCRINOLOGY AND METABOLISM, 2012, 2 (03) : 145 - 150
  • [8] Papillary carcinoma of the thyroid gland in a child of thyrotoxicosis patient receiving radioactive iodine therapy: report of a case
    Surasak Sangkhathat
    Sakda Patrapinyokul
    Piyawan Chiengkriwate
    Supika Kritsaneepaiboon
    Kanita Kayasut
    Teerapol Pramphapa
    Matinee Maipang
    Pediatric Surgery International, 2008, 24 : 747 - 750
  • [9] Radioactive iodine ablation may not decrease the risk of recurrence in intermediate-risk papillary thyroid carcinoma
    Kim, Seo Ki
    Woo, Jung-Woo
    Lee, Jun Ho
    Park, Inhye
    Choe, Jun-Ho
    Kim, Jung-Han
    Kim, Jee Soo
    ENDOCRINE-RELATED CANCER, 2016, 23 (05) : 367 - 376
  • [10] Mucoepidermoid carcinoma post-radioactive iodine treatment of papillary thyroid carcinoma: unique presentation and putative etiologic association
    Saluja, Karan
    Butler, Randall T.
    Pytynia, Kristen B.
    Zhao, Bihong
    Karni, Ron J.
    Weber, Randal S.
    El-Naggar, Adel K.
    HUMAN PATHOLOGY, 2017, 68 : 189 - 192
12345